Ads like these are all over social media. Too often, doctors warn, the companies behind the ads appear to prioritize business ...
The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...
In a statement, Trotter described his experience as a child with older relatives who struggled with Type 2 diabetes. Trotter ...
In her last week at AdExchanger, Senior Editor Alyssa Boyle reflects on three years of change, and stasis, in the CTV space.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
A nutrition scientist is calling out the growing wave of "nature's Ozempic" and other quick-weight loss products, calling out ...
Health officials in Denmark, where Ozempic manufacturer Novo Nordisk is ... businesses and influencers to remove online and social media ads for weight-loss prescription-only medicines targeted ...
The Food and Drug Administration said Friday the shortage of Ozempic and Wegovy is over ... its weight-loss offerings in a Super Bowl ad as “affordable” and “doctor-trusted,” while ...
In 2014, Simpson appeared in ads at age 33, showing off her post-baby ... a shadow of its $6.7 billion peak. By comparison, Ozempic-maker Novo Nordisk is valued at $2.6 trillion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback